The culture of the FDA didn’t spring into being this year, of course. This book covers their failures to regulate foreign manufacturing of generic drugs and it substantially dented my previous belief that generic versions of drugs are equal to the branded. The book is, however, about twice as long as it should be and you may prefer this podcast with the author.
The culture of the FDA didn’t spring into being this year, of course. This book covers their failures to regulate foreign manufacturing of generic drugs and it substantially dented my previous belief that generic versions of drugs are equal to the branded. The book is, however, about twice as long as it should be and you may prefer this podcast with the author.
Before writing the book Katherine Eban wrote an article for CNN Money on Ranbaxy: http://www.sacw.net/article4564.html
(The fact that CNN doesn’t host the article anymore it’s worth noting; it seems someone got them to take it down)